Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
, opens new tab said on Monday its pill-based treatment for COVID-19 did not meet the primary endpoint of showing a statistically significant reduction of 15 common symptoms of the illness in ...
Reuters
3 小時前